D & R Pharmaceutical Services, LLC — Federal Contractor Profile

Contractor Overview

Total Contract Value: $5,168,922 ($5.2M)

Total Awards: 4

Company Profile

D & R Pharmaceutical Services, LLC is a federal contractor with a total government contract value of $5.2 million, spanning four contracts averaging $1.29 million each. The company does not have any recent contracts, indicating a potential lull in activity. Given the absence of specific information on their core capabilities and the agencies they serve, it is challenging to provide a detailed analysis. However, based on the available data, D & R Pharmaceutical Services, LLC appears to be involved in pharmaceutical services, likely supporting government agencies with specialized pharmaceutical needs. The company has not engaged in any sole-source contracts, suggesting a preference for competitive bidding processes. Without specific details on their performance and the nature of their contracts, it is difficult to assess their track record and strategic direction. The lack of recent contracts and the absence of specific agency clients suggest a need for further investigation into their current business activities and future prospects.

Specializations

• Pharmaceutical Services
• Drug Testing
• Pharmaceutical Supply Chain Management
• Pharmaceutical Quality Assurance
• Pharmaceutical Compliance

Contractor Metrics

Average Contract Size: $0

Competitive Win Rate: 100%

Agency Concentration: N/A

Growth Trajectory: N/A

Sole Source Rate: 0%

Recompete Rate: N/A

Competitive Position

D & R Pharmaceutical Services, LLC appears to be a niche player in the pharmaceutical services sector, as evidenced by the absence of sole-source contracts and the preference for competitive bidding. While the company has not provided specific details on their capabilities, their focus on pharmaceutical services suggests they may be a specialized provider, potentially competing with other niche players in the market. However, without more information on their performance and market share, it is difficult to determine their exact competitive position.

Value to Taxpayers

Given the company's preference for competitive bidding and the absence of sole-source contracts, it is likely that D & R Pharmaceutical Services, LLC is providing value to taxpayers through fair competition. However, the lack of recent contracts and specific details on their performance and services makes it challenging to provide a comprehensive assessment of their value. The company's focus on pharmaceutical services suggests they may be able to offer specialized and high-quality services, which could be beneficial to government agencies.

Agency Relationships

While D & R Pharmaceutical Services, LLC has not provided specific information on their agency clients, the absence of recent contracts and the lack of detailed information on their relationships with government agencies makes it difficult to assess their dependency patterns. Without more information, it is unclear which agencies rely most on the company and whether there are any concentration risks.

Red Flags

• No recent contracts: This could indicate a lack of current activity or potential financial instability.
• Lack of specific agency clients: This makes it difficult to assess the company's dependency patterns and potential risks.
• No sole-source contracts: While this suggests a preference for competitive bidding, it may also indicate a lack of specialized capabilities that could be critical for certain government projects.

Green Flags

• Preference for competitive bidding: This suggests the company is committed to fair competition and may be a reliable partner for government agencies.
• Absence of sole-source contracts: This indicates a focus on fair competition and may suggest a strong track record in the pharmaceutical services sector.
• Focus on pharmaceutical services: This specialization could indicate a niche market position and potential for high-quality, specialized services.

Key Contracts

D & R Pharmaceutical Services, LLC has four contracts totaling $5.2 million, averaging $1.29 million each. While the company does not provide specific details on the nature of these contracts, the absence of recent contracts and the lack of information on their performance and services makes it challenging to assess their capabilities and strategic direction. The company's focus on pharmaceutical services suggests they may be a specialized provider, potentially competing with other niche players in the market. However, without more information on their performance and market share, it is difficult to determine their exact competitive position and strategic direction.

Frequently Asked Questions

Recent Federal Contracts

D & R Pharmaceutical Services, LLC has 1 federal contracts on record. Below are the largest awards:

Related Pages